Digistain
YC S21 ↗London, GB · Founded 2019 · 40 employees · 1 known investors
Digistain develops imaging technology to grade breast cancer biopsies and assess cancer recurrence risk faster and more cost-effectively than traditional methods. The company serves breast oncologists and pathologists in clinical and diagnostic settings.
Founders & leadership· Y Combinator alumni (S21)
HA
Hemmel AmraniainFounder
CP
Chris PhillipsinFounder
Investors · 1
Companies House · registry record
View on Companies House ↗- Registered name
- DIGISTAIN LIMITED
- Company number
- 12329264
- Status
- Active
- Company type
- Private limited company
- Incorporated
- 22 Nov 2019
- Registered office
- Unit 101, Interchange Business Park Howard Way, Interchange Park, Newport Pagnell, MK16 9PY
- Nature of business (SIC)
- 72110 — Research and experimental development on biotechnology
- Accounts
- last made up to 31 Dec 2024 · next due 30 Sept 2026
- Confirmation statement
- last made up to 21 Nov 2025 · next due 5 Dec 2026
Current officers · 1
- Hemmel Amrania — director, appointed 22 Nov 2019
Source: Companies House public register · retrieved 24 Jul 2026. Contains public sector information licensed under the Open Government Licence v3.0.
In the news
- Sofia Angels Ventures buys into UK-based cancer treatment start-up Digistain | Bulgaria Deals News | SeeNewsseenews.com · 2022
- Sofia Angels Ventures Helps UK Medtech Startup Digistain Raise $1M to Fight Breast Cancertherecursive.com · 2022
- DigiStain gets Y Combinator funding - Digistain - Transformational breast cancer biomarker analyticsdigistain.co.uk · 2021
- Digistain raised $1 million seed from Sofia Angels Ventures and Y Combinator | Nordic 9nordic9.com